Company: SYRA
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-022023
Chunk: 22

Company: Syra Health Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 1
Chunk 22
---
5,580 from September 1, 2025
through May 31, 2026. The Company is occupying the space for executive and administrative offices. Rent expense for the nine months ended
September 30, 2025 and 2024 was
$89,621 and $109,098, which is included in selling, general and administrative expenses within the statements of operations.

The
components of lease expense were as follows:

 Schedule of Lease Expenses

    2025  
    2024 

    For
    the Nine Months Ended 

    September
    30, 

    2025  
    2024 
  
    Operating lease cost: 

    Amortization
    of ROU asset 
    $86,551  
    $96,825 
  
    Interest
    on lease liability 
     3,070  
     1,065 
  
    Total
    operating lease cost 
    $89,621  
    $97,890 

    2025  
    2024 

    For
                                            the Three Months Ended 

    September
    30, 

    2025  
    2024 
  
    Operating lease cost: 

    Amortization
    of ROU asset 
    $22,074  
    $33,627 
  
    Interest
    on lease liability 
     294  
     - 
  
    Total
    operating lease cost 
    $22,368  
    $33,627 

Supplemental
balance sheet information related to leases was as follows:

 Schedule of Supplemental Balance Sheet Information

    September 30, 2025  
    December 31, 2024 
  
    Operating lease: 

    Operating lease assets 
    $43,450  
    $299,190 

    Current portion of operating lease liability, related party 
    $43,450  
     111,978 
  
    Noncurrent operating lease liability, related party 
     -  
     187,212 
  
    Total operating lease liability 
    $43,450  
    $299,190 

    Weighted average remaining lease term: 

    Operating leases 
     0.67 years  
     2.50 years 

    Weighted average discount rate: 

    Operating lease 
     7.